Cargando…

Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge

BACKGROUND: Myocardial hypertrophy and dysfunction are key features of metabolic heart disease due to dietary excess. Metabolic heart disease manifests primarily as diastolic dysfunction but may progress to systolic dysfunction, although the mechanism is poorly understood. Liver kinase B1 (LKB1) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Edward J., Calamaras, Timothy, Elezaby, Aly, Sverdlov, Aaron, Qin, Fuzhong, Luptak, Ivan, Wang, Ke, Sun, Xinxin, Vijay, Andrea, Croteau, Dominique, Bachschmid, Markus, Cohen, Richard A., Walsh, Kenneth, Colucci, Wilson S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859355/
https://www.ncbi.nlm.nih.gov/pubmed/26722122
http://dx.doi.org/10.1161/JAHA.115.002277
_version_ 1782430949668028416
author Miller, Edward J.
Calamaras, Timothy
Elezaby, Aly
Sverdlov, Aaron
Qin, Fuzhong
Luptak, Ivan
Wang, Ke
Sun, Xinxin
Vijay, Andrea
Croteau, Dominique
Bachschmid, Markus
Cohen, Richard A.
Walsh, Kenneth
Colucci, Wilson S.
author_facet Miller, Edward J.
Calamaras, Timothy
Elezaby, Aly
Sverdlov, Aaron
Qin, Fuzhong
Luptak, Ivan
Wang, Ke
Sun, Xinxin
Vijay, Andrea
Croteau, Dominique
Bachschmid, Markus
Cohen, Richard A.
Walsh, Kenneth
Colucci, Wilson S.
author_sort Miller, Edward J.
collection PubMed
description BACKGROUND: Myocardial hypertrophy and dysfunction are key features of metabolic heart disease due to dietary excess. Metabolic heart disease manifests primarily as diastolic dysfunction but may progress to systolic dysfunction, although the mechanism is poorly understood. Liver kinase B1 (LKB1) is a key activator of AMP‐activated protein kinase and possibly other signaling pathways that oppose myocardial hypertrophy and failure. We hypothesized that LKB1 is essential to the heart's ability to withstand the metabolic stress of dietary excess. METHODS AND RESULTS: Mice heterozygous for cardiac LKB1 were fed a control diet or a high‐fat, high‐sucrose diet for 4 months. On the control diet, cardiac LKB1 hearts had normal structure and function. After 4 months of the high‐fat, high‐sucrose diet, there was left ventricular hypertrophy and diastolic dysfunction in wild‐type mice. In cardiac LKB1 (versus wild‐type) mice, high‐fat, high‐sucrose feeding caused more hypertrophy (619 versus 553 μm(2), P<0.05), the de novo appearance of systolic dysfunction (left ventricular ejection fraction; 41% versus 59%, P<0.01) with left ventricular dilation (3.6 versus 3.2 mm, P<0.05), and more severe diastolic dysfunction with progression to a restrictive filling pattern (E/A ratio; 5.5 versus 1.3, P=0.05). Myocardial dysfunction in hearts of cardiac LKB1 mice fed the high‐fat, high‐sucrose diet was associated with evidence of increased apoptosis and apoptotic signaling via caspase 3 and p53/PUMA (p53 upregulated modulator of apoptosis) and more severe mitochondrial dysfunction. CONCLUSIONS: Partial deficiency of cardiac LKB1 promotes the adverse effects of a high‐fat, high‐sucrose diet on the myocardium, leading to worsening of diastolic function and the de novo appearance of systolic dysfunction. LKB1 plays a key role in protecting the heart from the consequences of metabolic stress.
format Online
Article
Text
id pubmed-4859355
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48593552016-05-20 Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge Miller, Edward J. Calamaras, Timothy Elezaby, Aly Sverdlov, Aaron Qin, Fuzhong Luptak, Ivan Wang, Ke Sun, Xinxin Vijay, Andrea Croteau, Dominique Bachschmid, Markus Cohen, Richard A. Walsh, Kenneth Colucci, Wilson S. J Am Heart Assoc Original Research BACKGROUND: Myocardial hypertrophy and dysfunction are key features of metabolic heart disease due to dietary excess. Metabolic heart disease manifests primarily as diastolic dysfunction but may progress to systolic dysfunction, although the mechanism is poorly understood. Liver kinase B1 (LKB1) is a key activator of AMP‐activated protein kinase and possibly other signaling pathways that oppose myocardial hypertrophy and failure. We hypothesized that LKB1 is essential to the heart's ability to withstand the metabolic stress of dietary excess. METHODS AND RESULTS: Mice heterozygous for cardiac LKB1 were fed a control diet or a high‐fat, high‐sucrose diet for 4 months. On the control diet, cardiac LKB1 hearts had normal structure and function. After 4 months of the high‐fat, high‐sucrose diet, there was left ventricular hypertrophy and diastolic dysfunction in wild‐type mice. In cardiac LKB1 (versus wild‐type) mice, high‐fat, high‐sucrose feeding caused more hypertrophy (619 versus 553 μm(2), P<0.05), the de novo appearance of systolic dysfunction (left ventricular ejection fraction; 41% versus 59%, P<0.01) with left ventricular dilation (3.6 versus 3.2 mm, P<0.05), and more severe diastolic dysfunction with progression to a restrictive filling pattern (E/A ratio; 5.5 versus 1.3, P=0.05). Myocardial dysfunction in hearts of cardiac LKB1 mice fed the high‐fat, high‐sucrose diet was associated with evidence of increased apoptosis and apoptotic signaling via caspase 3 and p53/PUMA (p53 upregulated modulator of apoptosis) and more severe mitochondrial dysfunction. CONCLUSIONS: Partial deficiency of cardiac LKB1 promotes the adverse effects of a high‐fat, high‐sucrose diet on the myocardium, leading to worsening of diastolic function and the de novo appearance of systolic dysfunction. LKB1 plays a key role in protecting the heart from the consequences of metabolic stress. John Wiley and Sons Inc. 2015-12-31 /pmc/articles/PMC4859355/ /pubmed/26722122 http://dx.doi.org/10.1161/JAHA.115.002277 Text en © 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Miller, Edward J.
Calamaras, Timothy
Elezaby, Aly
Sverdlov, Aaron
Qin, Fuzhong
Luptak, Ivan
Wang, Ke
Sun, Xinxin
Vijay, Andrea
Croteau, Dominique
Bachschmid, Markus
Cohen, Richard A.
Walsh, Kenneth
Colucci, Wilson S.
Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge
title Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge
title_full Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge
title_fullStr Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge
title_full_unstemmed Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge
title_short Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge
title_sort partial liver kinase b1 (lkb1) deficiency promotes diastolic dysfunction, de novo systolic dysfunction, apoptosis, and mitochondrial dysfunction with dietary metabolic challenge
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859355/
https://www.ncbi.nlm.nih.gov/pubmed/26722122
http://dx.doi.org/10.1161/JAHA.115.002277
work_keys_str_mv AT milleredwardj partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT calamarastimothy partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT elezabyaly partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT sverdlovaaron partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT qinfuzhong partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT luptakivan partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT wangke partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT sunxinxin partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT vijayandrea partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT croteaudominique partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT bachschmidmarkus partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT cohenricharda partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT walshkenneth partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge
AT colucciwilsons partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge